These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions. McClelland HA Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966 [No Abstract] [Full Text] [Related]
25. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models. Casey DE Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821 [No Abstract] [Full Text] [Related]
26. Fluphenazine-induced extrapyramidal side effects in a horse. Brashier M Vet Clin North Am Equine Pract; 2006 Apr; 22(1):e37-45. PubMed ID: 16627093 [No Abstract] [Full Text] [Related]
27. Nigella sativa Oil Reduces Extrapyramidal Symptoms (EPS)-Like Behavior in Haloperidol-Treated Rats. Malik T; Hasan S; Pervez S; Fatima T; Haleem DJ Neurochem Res; 2016 Dec; 41(12):3386-3398. PubMed ID: 27752803 [TBL] [Abstract][Full Text] [Related]
28. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. McEvoy JP J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370 [TBL] [Abstract][Full Text] [Related]
29. Anticholinergics to treat antipsychotic-induced extrapyramidal symptoms: Time to avoid this practice. Koola MM Asian J Psychiatr; 2018 Jan; 31():100-101. PubMed ID: 29454175 [No Abstract] [Full Text] [Related]
31. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Casey DE Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453 [TBL] [Abstract][Full Text] [Related]
32. [Acute-onset extrapyramidal syndromes caused by drugs]. Montoya Cabrera MA; López Martín G; Baca Rodríguez LC; Porcayo Vergara F; Hernández Zamora A; Juárez Aragón G Bol Med Hosp Infant Mex; 1981; 38(4):607-15. PubMed ID: 6117295 [TBL] [Abstract][Full Text] [Related]
33. Recognition and treatment of rabbit syndrome, an uncommon complication of neuroleptic therapies. Todd R; Lippmann S; Manshadi M; Chang A Am J Psychiatry; 1983 Nov; 140(11):1519-20. PubMed ID: 6137964 [TBL] [Abstract][Full Text] [Related]
34. [Iatrogenic extrapyramidal disorders]. Ludin HP Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812 [TBL] [Abstract][Full Text] [Related]
35. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs. Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331 [TBL] [Abstract][Full Text] [Related]
36. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Weiden PJ; Mann JJ; Haas G; Mattson M; Frances A Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321 [TBL] [Abstract][Full Text] [Related]
37. A controlled trial of amantadine in drug-induced extrapyramidal disorders. DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE Psychopharmacol Bull; 1977 Jul; 13(3):31-3. PubMed ID: 18755 [No Abstract] [Full Text] [Related]
39. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs]. Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083 [No Abstract] [Full Text] [Related]